{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:25:38Z","timestamp":1772119538242,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T00:00:00Z","timestamp":1765929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T00:00:00Z","timestamp":1765929600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s10147-025-02913-z","type":"journal-article","created":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T05:38:18Z","timestamp":1765949898000},"page":"271-280","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic and clinicopathological implications of mismatch-repair deficiency and MLH1 promoter methylation status in endometrial carcinoma"],"prefix":"10.1007","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8727-8958","authenticated-orcid":false,"given":"Mayuko","family":"Goda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4709-7340","authenticated-orcid":false,"given":"Gou","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0625-6018","authenticated-orcid":false,"given":"Katsuya","family":"Iuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2750-4308","authenticated-orcid":false,"given":"Koji","family":"Horie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9637-9187","authenticated-orcid":false,"given":"Kiwamu","family":"Akagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,17]]},"reference":[{"issue":"7447","key":"2913_CR1","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/nature12113","volume":"497","author":"C Kandoth","year":"2013","unstructured":"Cancer Genome Atlas Research N, Kandoth C, Schultz N et al (2013) Integrated genomic characterization of endometrial carcinoma. Nature 497(7447):67\u201373","journal-title":"Nature"},{"issue":"2","key":"2913_CR2","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/bjc.2015.190","volume":"113","author":"A Talhouk","year":"2015","unstructured":"Talhouk A, McConechy MK, Leung S et al (2015) A clinically applicable molecular-based classification for endometrial cancers. Br J Cancer 113(2):299\u2013310","journal-title":"Br J Cancer"},{"issue":"1","key":"2913_CR3","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1136\/ijgc-2020-002230","volume":"31","author":"N Concin","year":"2021","unstructured":"Concin N, Matias-Guiu X, Vergote I et al (2021) ESGO\/ESTRO\/ESP guidelines for the management of patients with endometrial carcinoma. Int J Gynecol Cancer 31(1):12\u201339","journal-title":"Int J Gynecol Cancer"},{"issue":"5","key":"2913_CR4","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1002\/cncr.30496","volume":"123","author":"A Talhouk","year":"2017","unstructured":"Talhouk A, McConechy MK, Leung S et al (2017) Confirmation of promise: a simple, genomics-based clinical classifier for endometrial cancer. Cancer 123(5):802\u2013813","journal-title":"Cancer"},{"key":"2913_CR5","unstructured":"IARC (2020) WHO classification of tumors. Female genital tumours"},{"issue":"5","key":"2913_CR6","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2023.34.e85","volume":"34","author":"JS Berek","year":"2023","unstructured":"Berek JS, Matias-Guiu X, Creutzberg C et al (2023) FIGO staging of endometrial cancer. J Gynecol Oncol 34(5):e85","journal-title":"J Gynecol Oncol"},{"issue":"15","key":"2913_CR7","doi-asserted-by":"publisher","first-page":"7810","DOI":"10.1158\/0008-5472.CAN-06-1114","volume":"66","author":"H Hampel","year":"2006","unstructured":"Hampel H, Frankel W, Panescu J et al (2006) Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients. Cancer Res 66(15):7810\u20137817","journal-title":"Cancer Res"},{"issue":"18","key":"2913_CR8","doi-asserted-by":"publisher","first-page":"3172","DOI":"10.1002\/cncr.32203","volume":"125","author":"RM Kahn","year":"2019","unstructured":"Kahn RM, Gordhandas S, Maddy BP et al (2019) Universal endometrial cancer tumor typing: how much has immunohistochemistry, microsatellite instability, and MLH1 methylation improved the diagnosis of Lynch syndrome across the population? Cancer 125(18):3172\u20133183","journal-title":"Cancer"},{"key":"2913_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13030467","author":"J Leclerc","year":"2021","unstructured":"Leclerc J, Vermaut C, Buisine MP (2021) Diagnosis of Lynch syndrome and strategies to distinguish Lynch-related tumors from sporadic MSI\/dMMR tumors. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers13030467","journal-title":"Cancers (Basel)"},{"issue":"9","key":"2913_CR10","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1093\/jnci\/djab029","volume":"113","author":"CCB Post","year":"2021","unstructured":"Post CCB, Stelloo E, Smit V et al (2021) Prevalence and prognosis of lynch syndrome and sporadic mismatch repair deficiency in endometrial cancer. J Natl Cancer Inst 113(9):1212\u20131220","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"2913_CR11","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.ygyno.2017.07.003","volume":"146","author":"CM Cosgrove","year":"2017","unstructured":"Cosgrove CM, Cohn DE, Hampel H et al (2017) Epigenetic silencing of MLH1 in endometrial cancers is associated with larger tumor volume, increased rate of lymph node positivity and reduced recurrence-free survival. Gynecol Oncol 146(3):588\u2013595","journal-title":"Gynecol Oncol"},{"issue":"3","key":"2913_CR12","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1002\/cam4.3691","volume":"10","author":"M Loukovaara","year":"2021","unstructured":"Loukovaara M, Pasanen A, Butzow R (2021) Mismatch repair protein and MLH1 methylation status as predictors of response to adjuvant therapy in endometrial cancer. Cancer Med 10(3):1034\u20131042","journal-title":"Cancer Med"},{"key":"2913_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/cancers10090279","author":"J Kim","year":"2018","unstructured":"Kim J, Kong JK, Yang W et al (2018) DNA mismatch repair protein immunohistochemistry and MLH1 promotor methylation testing for practical molecular classification and the prediction of prognosis in endometrial cancer. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers10090279","journal-title":"Cancers (Basel)"},{"issue":"7","key":"2913_CR14","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1053\/j.gastro.2008.02.094","volume":"134","author":"T Nagasaka","year":"2008","unstructured":"Nagasaka T, Koi M, Kloor M et al (2008) Mutations in both KRAS and BRAF may contribute to the methylator phenotype in colon cancer. Gastroenterology 134(7):1950\u20131960","journal-title":"Gastroenterology"},{"key":"2913_CR15","unstructured":"Japan Society of Obstetrics and Gynecology. Patient annual report for 2021 [Available from: https:\/\/fa.kyorin.co.jp\/jsog\/readPDF.php?file=75\/12\/075121643.pdf]"},{"issue":"5","key":"2913_CR16","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1111\/cas.16121","volume":"115","author":"MK Kato","year":"2024","unstructured":"Kato MK, Fujii E, Asami Y et al (2024) Clinical features and impact of p53 status on sporadic mismatch repair deficiency and Lynch syndrome in uterine cancer. Cancer Sci 115(5):1646\u20131655","journal-title":"Cancer Sci"},{"issue":"2","key":"2913_CR17","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.ygyno.2017.08.016","volume":"147","author":"K Takahashi","year":"2017","unstructured":"Takahashi K, Sato N, Sugawara T et al (2017) Clinical characteristics of Lynch-like cases collaterally classified by Lynch syndrome identification strategy using universal screening in endometrial cancer. Gynecol Oncol 147(2):388\u2013395","journal-title":"Gynecol Oncol"},{"issue":"1","key":"2913_CR18","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1093\/jjco\/hyaa142","volume":"51","author":"A Yamamoto","year":"2021","unstructured":"Yamamoto A, Yamaguchi T, Suzuki O et al (2021) Prevalence and molecular characteristics of DNA mismatch repair deficient endometrial cancer in a Japanese hospital-based population. Jpn J Clin Oncol 51(1):60\u201369","journal-title":"Jpn J Clin Oncol"},{"key":"2913_CR19","first-page":"1","volume":"2021","author":"K Akagi","year":"2021","unstructured":"Akagi K, Oki E, Taniguchi H et al (2021) The real-world data on microsatellite instability status in various unresectable or metastatic solid tumors. Cancer Sci 2021:1","journal-title":"Cancer Sci"},{"issue":"4","key":"2913_CR20","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1200\/JCO.18.00283","volume":"37","author":"A Latham","year":"2019","unstructured":"Latham A, Srinivasan P, Kemel Y et al (2019) Microsatellite instability is associated with the presence of Lynch syndrome pan-cancer. J Clin Oncol 37(4):286\u2013295","journal-title":"J Clin Oncol"},{"issue":"6","key":"2913_CR21","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2021.32.e79","volume":"32","author":"E Kaneko","year":"2021","unstructured":"Kaneko E, Sato N, Sugawara T et al (2021) MLH1 promoter hypermethylation predicts poorer prognosis in mismatch repair deficiency endometrial carcinomas. J Gynecol Oncol 32(6):e79","journal-title":"J Gynecol Oncol"},{"issue":"7","key":"2913_CR22","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1038\/s41379-020-0501-8","volume":"33","author":"A Pasanen","year":"2020","unstructured":"Pasanen A, Loukovaara M, Butzow R (2020) Clinicopathological significance of deficient DNA mismatch repair and MLH1 promoter methylation in endometrioid endometrial carcinoma. Mod Pathol 33(7):1443\u20131452","journal-title":"Mod Pathol"},{"issue":"1","key":"2913_CR23","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3802\/jgo.2015.26.1.40","volume":"26","author":"M Kato","year":"2015","unstructured":"Kato M, Takano M, Miyamoto M et al (2015) DNA mismatch repair-related protein loss as a prognostic factor in endometrial cancers. J Gynecol Oncol 26(1):40\u201345","journal-title":"J Gynecol Oncol"},{"issue":"11","key":"2913_CR24","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1200\/JCO.2005.04.1574","volume":"24","author":"D Black","year":"2006","unstructured":"Black D, Soslow RA, Levine DA et al (2006) Clinicopathologic significance of defective DNA mismatch repair in endometrial carcinoma. J Clin Oncol 24(11):1745\u20131753","journal-title":"J Clin Oncol"},{"issue":"3","key":"2913_CR25","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1002\/path.5372","volume":"250","author":"A Leon-Castillo","year":"2020","unstructured":"Leon-Castillo A, Britton H, McConechy MK et al (2020) Interpretation of somatic POLE mutations in endometrial carcinoma. J Pathol 250(3):323\u2013335","journal-title":"J Pathol"},{"issue":"15","key":"2913_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17152483","volume":"17","author":"W Szatkowski","year":"2025","unstructured":"Szatkowski W, Nowak-Jastrz\u0105b M, Kluz T et al (2025) Clinicopathological features and risk stratification of multiple-classifier endometrial cancers: a multicenter study from Poland. Cancers (Basel) 17(15):2483","journal-title":"Cancers (Basel)"},{"issue":"7","key":"2913_CR27","first-page":"967","volume":"30","author":"L Seeber","year":"2020","unstructured":"Seeber L et al (2020) Mismatch repair deficiency and MLH1 promoter methylation in endometrial carcinoma: clinicopathological correlations and outcomes. Int J Gynecol Cancer 30(7):967\u2013975","journal-title":"Int J Gynecol Cancer"},{"key":"2913_CR28","first-page":"113","volume":"199","author":"I Capasso","year":"2025","unstructured":"Capasso I, Cerami C, Vatrano S et al (2025) MLH1 promoter hypermethylation defines a distinct subset of mismatch repair\u2013deficient endometrial carcinomas with aggressive features. Eur J Cancer 199:113\u2013123","journal-title":"Eur J Cancer"},{"issue":"2","key":"2913_CR29","first-page":"245","volume":"109","author":"I Zighelboim","year":"2007","unstructured":"Zighelboim I, Goodfellow PJ, Gao F et al (2007) Microsatellite instability and MLH1 promoter methylation in endometrial carcinoma: clinical significance. Cancer 109(2):245\u2013250","journal-title":"Cancer"},{"issue":"2","key":"2913_CR30","first-page":"310","volume":"153","author":"G Hom-Tedla","year":"2019","unstructured":"Hom-Tedla G et al (2019) Prognostic impact of MLH1 promoter methylation in endometrial cancer: a population-based study. Gynecol Oncol 153(2):310\u2013316","journal-title":"Gynecol Oncol"},{"issue":"3","key":"2913_CR31","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1097\/PAS.0000000000000783","volume":"41","author":"EA Sloan","year":"2017","unstructured":"Sloan EA, Ring KL, Willis BC et al (2017) PD-L1 expression in mismatch repair-deficient endometrial carcinomas, including Lynch syndrome-associated and MLH1 promoter hypermethylated tumors. Am J Surg Pathol 41(3):326\u2013333","journal-title":"Am J Surg Pathol"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-025-02913-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10147-025-02913-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-025-02913-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T04:07:55Z","timestamp":1769486875000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10147-025-02913-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,17]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["2913"],"URL":"https:\/\/doi.org\/10.1007\/s10147-025-02913-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7235357\/v1","asserted-by":"object"}]},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"value":"1341-9625","type":"print"},{"value":"1437-7772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,17]]},"assertion":[{"value":"6 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}